StageZero Life Sciences Ltd.
SZLS.TO
Price:
$0.04
Market Cap:
$630.02K
StageZero Life Sciences Ltd., a vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in the United States and Canada. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is Aristotle, a multi-cancer panel test for simultaneously screening for various cancers from a single sample of blood with high sensitivity and specificity for each cancer. It also offers ColonSentry, a blood test to determine an individual's current risk for havin...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2004-01-07
Stock Exchange
TSX
Ticker
SZLS.TO
PE Ratio
[-0.25]
ROE
[9.59%]
Current Ratio
[0.02]
Dividend Yield
[0%]
Enterprise Value
[2.75M]
Dividend History
The ROE as of December 2025 (TTM) for StageZero Life Sciences Ltd. (SZLS.TO) is 9.59%
According to StageZero Life Sciences Ltd.’s latest financial reports and current stock price. The company's current ROE is 9.59%. This represents a change of 70.78% compared to the average of 5.62% of the last 4 quarters.
StageZero Life Sciences Ltd. (SZLS.TO) Historical ROE (quarterly & annually)
How has SZLS.TO ROE performed in the past?
The mean historical ROE of StageZero Life Sciences Ltd. over the last ten years is 34.52%. The current 9.59% ROE has changed -72.21% with respect to the historical average. Over the past ten years (40 quarters), SZLS.TO's ROE was at its highest in in the September 2015 quarter at 6.49%. The ROE was at its lowest in in the June 2015 quarter at -107.11%.
Average
34.52%
Median
89.64%
Minimum
-506.95%
Maximum
556.47%
StageZero Life Sciences Ltd. (SZLS.TO) ROE by Quarter and Year
Discovering the peaks and valleys of StageZero Life Sciences Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 617.81%
Maximum Annual ROE = 556.47%
Minimum Annual Increase = -210.66%
Minimum Annual ROE = -506.95%
| Year | ROE | Change |
|---|---|---|
| 2022 | 152.14% | -156.14% |
| 2021 | -270.98% | -148.70% |
| 2020 | 556.47% | 617.81% |
| 2019 | 77.52% | -4.92% |
| 2018 | 81.54% | -16.57% |
| 2017 | 97.73% | -21.83% |
| 2016 | 125.03% | -63.18% |
| 2015 | 339.53% | -210.66% |
| 2014 | -306.83% | -39.47% |
| 2013 | -506.95% | 406.06% |
StageZero Life Sciences Ltd. (SZLS.TO) Average ROE
How has SZLS.TO ROE performed in the past?
The current ROE of StageZero Life Sciences Ltd. (SZLS.TO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
145.88%
5-year avg
119.34%
10-year avg
34.52%
StageZero Life Sciences Ltd. (SZLS.TO) ROE vs. Peers
How is SZLS.TO’s ROE compared to its peers?
StageZero Life Sciences Ltd.’s ROE is less than SQI Diagnostics Inc. (447.09%), greater than Heritage Cannabis Holdings Corp. (-66.10%), less than Willow Biosciences Inc. (1.57%), greater than Clearmind Medicine Inc. (-164.77%), greater than Empower Clinics Inc. (0.04%), less than 4Front Ventures Corp. (24.18%), greater than The BC Bud Corporation (-158.24%), less than Bhang Inc. (510.77%), less than ScreenPro Security Inc. (153.79%), greater than Sunniva Inc. (-48.69%),
| Company | ROE | Market cap |
|---|---|---|
| 447.09% | $6.11M | |
| -66.10% | $4.72M | |
| 1.57% | $5.15M | |
| -164.77% | $5.07M | |
| 0.04% | $4.14M | |
| 24.18% | $4.58M | |
| -158.24% | $5.02M | |
| 510.77% | $4.70M | |
| 153.79% | $1.48M | |
| -48.69% | $6.08M |
Build a custom stock screener for StageZero Life Sciences Ltd. (SZLS.TO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like StageZero Life Sciences Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
StageZero Life Sciences Ltd. (SZLS.TO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like StageZero Life Sciences Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is StageZero Life Sciences Ltd.'s ROE?
How is the ROE calculated for StageZero Life Sciences Ltd. (SZLS.TO)?
What is the highest ROE for StageZero Life Sciences Ltd. (SZLS.TO)?
What is the 3-year average ROE for StageZero Life Sciences Ltd. (SZLS.TO)?
What is the 5-year average ROE for StageZero Life Sciences Ltd. (SZLS.TO)?
How does the current ROE for StageZero Life Sciences Ltd. (SZLS.TO) compare to its historical average?